PLUNKETT'S BIOTECH & GENETICS INDUSTRY TRENDS & STATISTICS 2015
Industry trends analysis, market data and competitive intelligence
Market forecasts and Industry Statistics
Link to our 5-minute video overview of this industry
Pages: 60 Statistical Tables Provided: 16 Geographic Focus: Global
A condensed market research report excerpted from Plunkett’s Biotech & Genetics Industry Almanac 2015, including forecasts and market estimates, technologies analysis and vital statistical tables. You will gain significant insights that can help you shape your own strategy for business development, product development and investments.
How is the industry evolving?
How is the industry being shaped by new technologies?
How is demand growing in emerging markets and mature economies?
What is the size of the market now and in the future?
Contents, Statistics, Forecasts and Analysis Include:
Major Trends Affecting the Biotech & Genetics Industry
1) The State of the Biotechnology Industry Today 2) A Short History of Biotechnology 3) Ethanol Production Soared, But U.S. Federal Subsidy Expires 4) Major Drug Companies Acquire or Partner With Smaller Biotech Firms 5) U.S. Drug Manufacturers Seek Tax Breaks by Acquiring Overseas Firms 6) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development 7) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance 8) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing 9) Vaccines and Viruses in Drug Delivery 10) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues/Drug Prices Soar 11) Biotech and Orphan Drugs Create New Revenues for Drug Firms 12) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce 13) Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs 14) Stem Cells—Multiple Sources Stem from New Technologies 15) Government Support for Stem Cell Research Evolves 16) Stem Cells—Therapeutic Cloning Techniques Advance 17) Stem Cells—A New Era of Tissue Replacement Takes Shape 18) Nanotechnology Converges with Biotech 19) Genetically Modified Seeds and Crops (GMOs) 20) Genetically Modified (GM) Foods 21) Molecular Farming of Plant-Based Pharmaceuticals 22) Cloning of Farm Animals/Meat Grown in the Laboratory 23) Selective Breeding, Zinc Fingers and Mutagenesis as Alternatives to GMOs 24) Immunotherapy Promises New Approach to Fighting Cancers 25) Technology Discussion—Genes and DNA 26) Technology Discussion—Proteins and Proteomics 27) Technology Discussion—Microarrays 28) Technology Discussion—DNA Chips 29) Technology Discussion—SNPs (“Snips”) 30) Technology Discussion—Combinatorial Chemistry 31) Technology Discussion—Synthetic Biology 32) Technology Discussion—Recombinant DNA 33) Technology Discussion—Polymerase Chain Reaction (PCR)
Biotech & Genetics Industry Statistics
1) Biotech Industry Overview 2) The U.S. Drug Discovery & Approval Process 3) U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2013 4) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2013 5) Employment in Life & Physical Science Occupations, U.S.: May 2013 6) Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2012-2014 7) U.S. Exports & Imports of Pharmaceutical Products: 2008-1st Quarter 2014 8) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2006-2022 9) U.S. Prescription Drug Expenditures: Selected Years, 1960-2022 10) Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2013 11) Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2013-2015 12) Global Area of Biotech Crops by Country: 2013 13) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2013 14) Sales by Geographic Area, PhRMA Member Companies: 2012 15) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2013 16) Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2012